Młody mężczyzna oglądający swoje włosy, zaniepokojony ich wypadaniem

Hair Loss, Acne, and Libido — Do They Share a Common Root Cause?

A receding hairline, stubborn acne, and swings in libido look like three separate problems — but in many men they're connected by one biological axis: testosterone, the enzyme 5-alpha-reductase, and the androgen receptor. We show how this axis genuinely links three seemingly unrelated symptoms, without repeating details we've already covered in our hair-loss articles.

Redakcja VitMode — Badania i biomarkerythe VitMode editorial team, no individual bylinesPublishedSeptember 25, 202612 min readAbout 12 min left

How this article was made

Author: Redakcja VitMode — Badania i biomarkery — the VitMode editorial team, no individual bylines
Method: Prepared from primary sources: clinical trials, meta-analyses and guidelines. We describe study findings separately from our interpretation.
Source verification: Cited PubMed papers are automatically checked for a matching identifier, title and publication year.
Medical review: none — this article has not been reviewed by a physician
Last updated: September 25, 2026

The content is educational and does not replace medical advice. Read the full editorial process

Table of contents

TL;DR — key takeaways

→Three problems, one question in the exam room
→The shared axis: testosterone → 5-alpha-reductase → DHT → androgen receptor
→Why this does NOT mean high DHT lowers libido
→Genetics: why it all comes together in some men and not others
→What this looks like in practice: three typical scenarios
→What is NOT part of this shared axis
→What to do if you notice two or three of these symptoms
→Limits of this model

Three problems, one question in the exam room

You're 29, 33, or 38. Your hairline at the temples is receding a bit faster than you'd like, acne you haven't had since high school keeps coming back along your jawline, and your libido is — there's no better word for it — uneven. Each of these three problems has its own explanation, its own article, its own specialist. But is it possible that in some men, all three stem from one shared source?

The answer is: yes, in some men there is a genuine shared biological axis — testosterone, the enzyme 5-alpha-reductase, dihydrotestosterone (DHT), and the androgen receptor — that can simultaneously affect hair follicles, sebaceous glands, and tissues tied to sexual function. That doesn't mean anyone with two of these three symptoms is dealing with exactly the same mechanism — but it's worth understanding what this connection actually looks like, instead of intuitively assuming "it's all testosterone."

The shared axis: testosterone → 5-alpha-reductase → DHT → androgen receptor

Testosterone circulating in the blood, on its own, has a limited effect on many target tissues. It's only after conversion by the enzyme 5-alpha-reductase into dihydrotestosterone (DHT) — a compound with several times higher affinity for the androgen receptor than testosterone itself — that strong activation of that receptor occurs in specific tissues. Crucially, this enzyme exists in two main isoforms (type 1 and type 2), distributed differently across tissues: type 1 dominates in the skin's sebaceous glands, while type 2 dominates in temporal/crown hair follicles and in reproductive-tract tissues.

This distribution explains why DHT can simultaneously miniaturize hair follicles at the temples (androgenetic alopecia), boost sebum production in the jaw and cheek sebaceous glands (acne), and — through the same androgen receptors also present in the central nervous system and genital tissues — affect sexual desire. Three different target organs, one shared molecular signal.

What does the research say?

Sexual side effects of 5-α-reductase inhibitors finasteride and dutasteride: A comprehensive review

Fertig RM, Gamret AC, Darwin E, Gaudi S · Dermatology Online Journal · 2017

Study findings

A systematic review found that 5-alpha-reductase inhibitors used to treat androgenetic alopecia are associated with an elevated risk of sexual dysfunction — reduced libido, erectile dysfunction, and ejaculation problems — in a subset of treated men. The authors note that blocking the conversion of testosterone to DHT affects not only peripheral tissues (skin, hair follicles) but also the central nervous system through changes in neurosteroid levels, which may explain effects on sexual desire independent of blood testosterone levels themselves.

Strong evidenceView the study on PubMed

This describes what the study found. Editorial interpretation follows in the text below.

Why this does NOT mean high DHT lowers libido

Myth

If drugs that block DHT lower libido in some men, that means high DHT is good for libido, and more DHT is always better.

Fact

That's an overreach. Normal, physiological levels of DHT and androgen receptor activity support healthy libido — but there's no good evidence that raising DHT above normal further improves it. The relationship isn't linear: dropping clearly below normal (as with enzyme-blocking drugs) is harmful, but that doesn't mean more is always better — we cover this same "threshold, not a straight line" pattern in more depth in our article on testosterone and libido.

In other words: the testosterone-DHT-androgen receptor axis is shared across all three symptoms, but that doesn't mean they always move in the same direction. A man with strongly androgen-responsive skin and scalp (clear acne, early hairline recession) doesn't necessarily also have libido problems — for many such men libido is perfectly normal, because local follicle and sebaceous-gland sensitivity to DHT is a different variable from overall axis activity in the brain and genital tissues.

Genetics: why it all comes together in some men and not others

A key piece of the puzzle is genetically determined androgen receptor sensitivity, largely dependent on the length of so-called CAG repeats in the androgen receptor gene (shorter repeats generally mean higher tissue sensitivity to a given DHT level). This explains why two men with identical blood testosterone levels can have completely different clinical pictures — one with clear acne and early hair loss, the other with neither symptom — despite the same "amount of hormone" circulating in the body.

Check your profile

Not sure which supplements actually make sense for you?

Answer a few short questions about your lifestyle, diet, sleep, and goals. VitMode will build your profile and show supplements worth considering — with reasoning and evidence strength.

Takes about 2 minutesBased on scientific evidence

Find supplements for me

Recommendations take your answers and the strength of the scientific evidence into account. A supplement's popularity has no bearing on whether it gets recommended.

What this looks like in practice: three typical scenarios

Scenario	What's happening	What it suggests
Jawline acne + early hairline recession, normal libido	Strong local 5-AR activity in skin and scalp, normal systemic axis activity	Classic picture of high tissue sensitivity to DHT without libido involvement — the most common pattern
All three symptoms at once	May suggest broadly higher androgenic activity OR a coincidence of independent causes (stress, sleep, diet)	Worth differentiating, not assuming one shared mechanism by default
Hair loss and acne improve on DHT-blocking drugs, but libido also drops	Side effect of a pharmacological intervention on the whole axis, not a natural course	Evidence that the axis is genuinely shared — but here it results from a deliberate intervention, not a spontaneous process

Three typical patterns of co-occurrence

What is NOT part of this shared axis

What to do if you notice two or three of these symptoms

The first step isn't guessing — it's careful observation and, if symptoms are significant, a consultation. A dermatologist will assess acne and the hair-loss pattern clinically and, if in doubt, order hormone testing (total and free testosterone, SHBG, sometimes DHEA-S). If a libido problem is clear-cut and persistent rather than fleeting, it's worth a separate consultation — our broad article on ten causes of low libido in men gives wider diagnostic context beyond the DHT axis alone.

Specific strategies for managing androgenetic alopecia — from finasteride to supportive supplementation, including whether creatine actually raises DHT enough to matter clinically — are covered in the dedicated articles linked above. We deliberately don't repeat those details here, to avoid diluting this piece's core message: that these three symptoms may, or may not, share a common source.

Limits of this model

Patients who notice two or three of these symptoms at once often assume one dramatic shared cause. In practice we most often find a mix: some genuinely shared biology, and some entirely independent causes that simply happened to coincide in time.

VitMode editorial team

Frequently asked questions

No. Local sensitivity of sebaceous glands and hair follicles to DHT are two separate, though related, variables — you can have one symptom pronounced without the other, depending on the genetically determined distribution of androgen receptors.

Not necessarily, and often the opposite. A drop in libido is more often linked to low, not high, testosterone, or to causes entirely unrelated to hormones (stress, sleep, relationships). Acne and hair loss alone don't tell you your testosterone level without bloodwork.

Yes, that's a documented risk — finasteride acts systemically on the whole 5-alpha-reductase axis, not only locally in the scalp, which is why it causes sexual side effects in some men. This is a topic to discuss with a doctor before starting therapy, not after.

They're a segment of the androgen receptor gene whose length correlates with tissue sensitivity to DHT — shorter repeats usually mean higher sensitivity. This is one reason two men with identical testosterone levels can have very different degrees of acne or hair loss.

Yes, it's worth consulting a doctor and considering a basic panel (total and free testosterone, SHBG), especially if symptoms are pronounced or appeared relatively suddenly. The result will help distinguish a shared hormonal cause from a coincidence of independent causes.

This question is genuinely debated, and the answer isn't clear-cut — we cover the scientific evidence in detail in our article on creatine, hair loss, and DHT. In short: the evidence for a clinically meaningful DHT increase from creatine supplementation is limited and mixed.

We don't recommend that. The co-occurrence of these three symptoms is a clue, not a diagnosis — each of them also has causes unrelated to DHT, and a final assessment requires a clinical exam and, often, bloodwork.

Sources (1)

Sources are numbered. PubMed items are automatically verified (identifier, title, year).

1Fertig et al. 2017 — Sexual side effects of 5-α-reductase inhibitors finasteride and dutasteride (Dermatol Online J)PubMed

Redakcja VitMode — Badania i biomarkery

VitMode editorial team — no individual bylines; content based on primary sources

VitMode Editorial — Lab Tests and Biomarkers is the VitMode editorial team responsible for: laboratory tests, interpreting results and ageing biomarkers. The team has no individual bylines — texts are prepared by VitMode editors from primary sources (clinical trials, meta-analyses, guidelines). Every cited PubMed paper is automatically checked for a matching identifier, title and publication year. The content is educational and does not replace medical advice. Factual errors can be reported in a comment under the post or through the contact form; corrections are made by the editorial team.